Home / Recalls / Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center / D-0154-2020

D-0154-2020 Class III Terminated

Recalled by Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center — West Columbia, SC

Recall Details

Product Type
Drugs
Report Date
November 6, 2019
Initiation Date
October 21, 2019
Termination Date
May 7, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19,390 syringes

Product Description

PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron 503B Outsourcing Facility 4500 12th St. Ext West Columbia, SC 29172, NDC 69374-919-10.

Reason for Recall

Incorrect labeling: Incorrect or missing lot and/or exp date

Distribution Pattern

Nationwide in the U.S.

Code Information

Lots: SU9079A, SU9079B, Exp 4/5/2020

Other recalls by Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center

  • D-0151-2020 Class II — del Nido Cardioplegia Solution, 1000 mL, Single-Dose Container, Rx Only Nephron (October 9, 2019)
  • D-0150-2020 Class II — Amino Acid Injection 50 g/1000 mL (50 mg/mL) 25 g L-Arginine HCl; 25 g L-Lysine (October 9, 2019)
  • D-0148-2020 Class II — PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride I (October 9, 2019)
  • D-0149-2020 Class II — PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine HCl 0.1% in 0.9% Sodium Chloride Inj (October 9, 2019)
  • D-0147-2020 Class II — PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 0.0625 in 0.9% Sodium Chlorid (October 9, 2019)